Preview Mode Links will not work in preview mode

Jun 10, 2021

Featuring a roundtable discussion with Drs Ian W Flinn, John M Pagel and Tanya Siddiqi, including the following topics:

  • Case: A woman in her late 60s with newly diagnosed chronic lymphocytic leukemia (CLL) who receives acalabrutinib — Gigi Chen, MD (0:00)
  • Case: A woman in her mid-60s with CLL who responds to ibrutinib but has an elevated absolute lymphocyte count — Laurie Matt-Amaral, MD, MPH (7:40)
  • Optimal choice and sequence of BTK inhibitors and Bcl-2 inhibitors in patients with CLL (11:58)
  • Case: A man in his late 70s with relapsed CLL who receives venetoclax/rituximab — Ranju Gupta, MD (22:08)
  • Case: A man in his mid-70s with relapsed CLL who is otherwise fit and receives first-line treatment with venetoclax/obinutuzumab — Dr Gupta (28:04)
  • Case: A woman in her late 80s with CLL who develops congestive heart failure on ibrutinib — Dr Chen (34:11)
  • Practical issues in the use of BTK inhibitors and Bcl-2 inhibitors for patients with CLL (38:40)

CME information and select publications